Received: from pps.filterd (pp-client-1.ph.ee [127.0.0.1]) by pp-client-1.ph.ee (8.18.1.11/8.18.1.11) with ESMTP id 66VBcb351472566 for ; Fri, 31 Jul 2026 14:45:29 +0300 Received: from mail1.rit.ee (213.184.53.4) by DB1PEPF00050A01.mail.protection.outlook.com (10.167.242.43) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.270.5 via Frontend Transport; Fri, 31 Jul 2026 11:45:30 +0000 Received: from exmb1.ph.ee (smtp.ph.ee [194.126.127.51]) by pp-client-1.ph.ee (PPS) with ESMTPS id 4fq851r7s3-1 (version=TLSv1.2 cipher=ECDHE-RSA-AES256-GCM-SHA384 bits=256 verify=NOT) for ; Fri, 31 Jul 2026 14:45:29 +0300 (EEST) Received: from ExMB3.ph.ee ([172.20.7.193]) by ExMB3.ph.ee ([172.20.7.193]) with mapi id 15.02.2562.043; Fri, 31 Jul 2026 14:45:28 +0300 Received: from ExMB3.ph.ee (172.20.7.193) by ExMB1.ph.ee (172.20.7.191) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.2.2562.43; Fri, 31 Jul 2026 14:45:28 +0300 Received: from DB1PEPF00050A01.eurprd03.prod.outlook.com (2603:10a6:10:3c3:cafe::8a) by DUZPR01CA0009.outlook.office365.com (2603:10a6:10:3c3::16) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.270.16 via Frontend Transport; Fri, 31 Jul 2026 11:45:31 +0000 Received: from DU0PR02MB8619.eurprd02.prod.outlook.com (2603:10a6:10:3eb::11) by DB9PR02MB7817.eurprd02.prod.outlook.com with HTTPS; Fri, 31 Jul 2026 11:45:34 +0000 Received: from DUZPR01CA0009.eurprd01.prod.exchangelabs.com (2603:10a6:10:3c3::16) by DU0PR02MB8619.eurprd02.prod.outlook.com (2603:10a6:10:3eb::11) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.270.15; Fri, 31 Jul 2026 11:45:31 +0000 From: =?utf-8?Q?Anneli_P=C3=A4rn_=28KVAL=29?= To: "Info - SOM" Subject: =?utf-8?Q?Selgitustaotlus_tervishoiuteenus?= =?utf-8?Q?te_korraldamise_seaduse_ohjeldus?= =?utf-8?Q?meetmete_s=C3=A4tete_rakendamise_koht?= =?utf-8?Q?a?= Date: Fri, 31 Jul 2026 14:45:28 +0300 Keywords: Mall Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_004F_01DD2102.98419930" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQI9MBx3yEVduJpVQ2L+VUvDbM48bg== Authentication-Results: spf=fail (sender IP is 213.184.53.4) smtp.mailfrom=ph.ee; dkim=pass (signature was verified) header.d=ph.ee;dmarc=pass action=none header.from=ph.ee;compauth=pass reason=100 X-CSE-ConnectionGUID: ZYNvRkO0ToilgrSJsHM65w== X-CSE-MsgGUID: 0ySGNwLQTliG+FHM2umAOw== X-ThreatScanner-Verdict: Negative X-IPAS-Result: =?us-ascii?q?A0HxAwDeiWxqdzx/fsJahBZbKYEKXjQEC0kdhDuIeoYUh?= =?us-ascii?q?BGQbgSGIodcDwEBAQEBAQoBAVEEAQEDAQOEfhiNUSAHATgTAQIBAgEDAgMBA?= =?us-ascii?q?QEBAQEBAQEBAQsBAQEEAQEBAgEBAgQDAQEBAQIQAUNJhk8BDIJbO4IWLIE0C?= =?us-ascii?q?hMBATgRAQZEAgQvGgwBBBuCe4IdB1AHoR6cPoEygQGCDAEBBgQDAgPcaYElC?= =?us-ascii?q?YFNhQWDVwEqgTUBAg6Dd0iDSXuCTyaDa4VHFYMvgmqCJnoSG4RwGo0QLIEYI?= =?us-ascii?q?gMmMywBDxE1ExcLBwWBZgMqLy0yPDIdgSM+FwgtWBsHBYEdgSsvhFMjGTZ8g?= =?us-ascii?q?S91SnUtahIXgRqDMQKCXwMLB2Y9NxQZBgGBNY0CYiCBe4EUgUIrlEOEEotio?= =?us-ascii?q?3cHK4JqgQuhYy4XhASNFJlUhiOSZSOodQIEAgQFAhg2gUkjgVyEJ1ADFwIPj?= =?us-ascii?q?l94AQKDNc04RzI8AQEBAgUCBwELAQEDCQEBgWhPAY9kLj5gAQE?= X-Talos-CUID: =?us-ascii?q?9a23=3Adr1TVWlx2fUDQ0mDjWpsdj2aWtfXOU/s6mnqIGj?= =?us-ascii?q?gNWFoTLKPcn2L2IY6ztU7zg=3D=3D?= X-Talos-MUID: 9a23:wNYjwQtpvXLNvnoyZM2n3CBZG+F3x52SDEEi0rsmnpOZMAVXJGLI X-IronPort-Anti-Spam-Filtered: true X-IronPort-AV: E=Sophos;i="6.25,196,1779138000"; d="scan'208,217";a="76472357" X-Amp-Result: SKIPPED(no attachment in message) X-Amp-File-Uploaded: False X-MS-Has-Attach: X-MS-TNEF-Correlator: x-ms-traffictypediagnostic: DB1PEPF00050A01:EE_|DU0PR02MB8619:EE_|DB9PR02MB7817:EE_ X-MS-Office365-Filtering-Correlation-Id: 72a02ab4-f675-4fb6-0f0b-08deeef93951 X-MS-Exchange-Transport-CrossTenantHeadersStamped: DU0PR02MB8619 X-MS-Exchange-Organization-ExpirationStartTime: 31 Jul 2026 11:45:30.9070 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: 72a02ab4-f675-4fb6-0f0b-08deeef93951 X-EOPAttributedMessage: 0 X-EOPTenantAttributedMessage: 8fe098d2-428d-4bd4-9803-7195fe96f0e2:0 X-MS-Exchange-Organization-MessageDirectionality: Incoming X-MS-PublicTrafficType: Email X-MS-Exchange-Organization-AuthSource: DB1PEPF00050A01.eurprd03.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Exchange-AtpMessageProperties: SA|SL X-DisclaimerOO: 1 X-MS-Exchange-Organization-SCL: -1 X-Microsoft-Antispam: BCL:0;ARA:13230040|704162111799003|82310400026|18003699003|5063699009|56012099006|11063799006|10067099003|19002099009|8096899003|55112099003|16102099003; X-Forefront-Antispam-Report: CIP:213.184.53.4;CTRY:EE;LANG:et;SCL:-1;SRV:;IPV:CAL;SFV:NSPM;H:mail1.rit.ee;PTR:mail1.rit.ee;CAT:NONE;SFS:(13230040)(704162111799003)(82310400026)(18003699003)(5063699009)(56012099006)(11063799006)(10067099003)(19002099009)(8096899003)(55112099003)(16102099003);DIR:INB; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 31 Jul 2026 11:45:30.7419 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 72a02ab4-f675-4fb6-0f0b-08deeef93951 X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: DB1PEPF00050A01.eurprd03.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-EndToEndLatency: 00:00:03.6566802 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0270.009 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(4710232)(4717077)(4999285)(920097)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?Ge/reu2m6UsA8F2O8DJs9tKZ0PbsK23oMngVYtIh0A5xDels30DPP0xwUCyU?= =?us-ascii?Q?5u0XBX8ugu8sm75wBkb5w+1Dpr0jqmv7wu9m4VyeSwuttyvO8arWkE6D1knm?= =?us-ascii?Q?nUZ19zSCOWeGH0EhXuNrF+A204yUgVa4fiiSXXDjHWFfqFprYVh8yWM0CgOl?= =?us-ascii?Q?tv8CsdS2hCNN6uZFC/rGBBgl720soo5/HCCwyDVNWvynB655QP6kvmxR1C1j?= =?us-ascii?Q?iszKLdnd38cn7VJsTKL1XPpdE645SDM/zBOb/X328I1EB1ldhrl+ZV8xPXuN?= =?us-ascii?Q?ohExcnlukkEbDOyIR42xQ0gk9wHuE14V6U3gM2bQ3fgBljxeXFcZ46YGiE6S?= =?us-ascii?Q?0yfqCTc+ct6pb1n9/H5mZtmC9jCBlKUHfL0dPuC2OmX6q2QbJ8QpabssNnJp?= =?us-ascii?Q?102vwYym9Y+LAkRZ7F1HYgrEBEKkayTJypMtrmnbqNVNg699T1On42qzhmdt?= =?us-ascii?Q?XVGSwd0GrN6JM+favoJHwJUDRJ973RiSUoIDhKjDmF7h9JTetdr1J48Q5cDs?= =?us-ascii?Q?3QYP3ik5EERKUJubZWeYrVbVxK/9UJ5Hw2mUsIyOlVFYUfxEcRStxwDcD8Ty?= =?us-ascii?Q?ermGKRUDVX4UtnOoYx/niR/fIhm84XcYcs+w8iGEoKE+4RUAQvTgWkfybBCM?= =?us-ascii?Q?FHSwVqZjNHAqeG9GTksRlMkUUluWzaoOne4zSI5y7IYmBmjcCLrwGh60Ujc+?= =?us-ascii?Q?tEGvnLGWPLrPdrmhYdNQkw/n/StvoyJdGL9mXnW+QH2YmUKpBob +fyZa0eov?= =?us-ascii?Q?LUwxWsbwx7fjW4kteoY72TbO3VtL0DfIbCh/m4ME+oEVvxjpK+GKp8uJd0ak?= =?us-ascii?Q?K5r1NHPQ8motvIInYAPBp1Y4ZkuM6zL+vxz2vyDp+M75WvZ9yDeoscSceWkg?= =?us-ascii?Q?9ZZV2FPF3WeOvAgEr9tKaw8sc9JmRmbm7znzTheababOydEaS9xf9tvjc83o?= =?us-ascii?Q?ZwOUCAw5FsU6bzgbn/HFKNgzG6mIUjOaC8mAcU7wA8z1xUyGE7oqTYoUzq+l?= =?us-ascii?Q?ZAfLN9LuzElxt52bkU7YciRY9rWmDD7rEQtNa7XIAJ7hD/TLwI8/qvyMadhr?= =?us-ascii?Q?ylok8eHgur+zw/8Uv/MkwhM4uhNSxcYSdMqRkopzumT/sQ8/v2S++O8vBuah?= =?us-ascii?Q?ooSkbAKr+nmcQvzXjQVK3QButfGIAQtOdRPVL/7Q/3QUxx86n1muZEKU6U07?= =?us-ascii?Q?qSiKrxZJkoDMhTSxxcz6mxF/wXFpzlU4DTEyd5YJ1KMtk+15DDrox61jGZIo?= =?us-ascii?Q?rKPOwdJEFzDPlOZjC1OwrmBcO9bvAA+MTUWILxGd8w19jOixxLnuIJ5QsgRc?= =?us-ascii?Q?l9l/6XsYvw5O7byddl/xMa9IyXLsPU92lm+jd+JBpcjAEsRczEyXOA7SbsAq?= =?us-ascii?Q?Vd8IWYvhY3MKYW3VcFcxblK0uHBVDPBIXD4brVHgw8On13G6zLe3SrH6Ssu+?= =?us-ascii?Q?kHRluQPUdH95oJm+aVGUpWx8U9E7ljR2eqwmrafLvOZlHZxvQNunsntjuz2M?= =?us-ascii?Q?dLt98ndC5bE3brCazmwqWKX/8URqD/lRiZ4b+ b1frwZyv5wTuRKl5alAMSKE?= =?us-ascii?Q?CQ63nfoO/KvQgagd+Kt43PSNmhFVpxrkThuQUMWg0pU1OqxJizmSY85sqAHY?= =?us-ascii?Q?w2BFLXfr6xo7I9b1YX9QParcUpYCa6zi1+K7i3HxdiMiLgzINOm10KYU9Yil?= =?us-ascii?Q?z8XHvhadygUcGDs1i8GuTPK8F6+DekAL9ay1YJXR8cbNa/CtMA46SmpYmxHu?= =?us-ascii?Q?A72fjZjyvrKlJM14DHcpoaZZAsIKGAJnDBNxyTxE5DvnN/BhV0T6Zz9r4m7Z?= =?us-ascii?Q?OYBnTblQc34gwLCrfpNlPFWm/A5NPmpieZI0heYFVRQScOLJAPcUz5KB2f/S?= =?us-ascii?Q?5qcjNHzsyaIvLPIRazCtdBYpe7ANukjeI41M+9tmLrJ9ezzey920F30CmG5n?= =?us-ascii?Q?w173CWS36XNy/SlAUfoMyPqsoBlYyx9LOcZg5bCTxGFD0YgM/sJYFbtVR+BE?= =?us-ascii?Q?9/4bL+TRuQYbLwneu98A+abp6JpDb8dKBkUMHtlbLzoKRnYM/L8qlKbUPIo5?= =?us-ascii?Q?i2rEn6auMelm1DURrfqIIa7/HlTuMjBIlOGt1TMkBdkbwi3m5QkyfgwHAN0s?= =?us-ascii?Q?IaRjLzHaIMLiGrRD+4BIwWOK0cmsLGs0NqVZ/4KUv6uoCascEFktpIpOlmEg?= =?us-ascii?Q?mVjMegtJUOVf8M2t1VbUDPcfhXlJavnrRLtgRdkuy7Y76h3geNhLCwE0yhcc?= =?us-ascii?Q?Vm5CwKEEPNq6nDtsV9eJyDtEA0sQ7W1ZBj5vtDE/uQ9mwu/KlIyhXoeqFonY?= =?us-ascii?Q?Z+dSEyewkD6ddpBe/hd+7CO Y0jasU6KUo2E8pDDaGTo/u+18F0gGvAl99LEs?= =?us-ascii?Q?TRWwjQicnjNQDBObMsxvOwHFqHgSLs7sJ0rphLA8uXczo87Zy1W6YaozFLi9?= =?us-ascii?Q?JEDOBa9vgevlMFrH44Sfph9fmrPNmeiH2p6MbpC8zbIFC1dAa8CrzFc7ZT5d?= =?us-ascii?Q?CRyb7SlyPfd+0p6eAkkBFjC6yMONqw4T5s7IoEMV3FGEhg/eeFFQv08jft9G?= =?us-ascii?Q?2v63a4/AA/k2WipTPBVuGRVsW65PgXacZgi1YvK/hZEghnek9kok9e6HHWVN?= =?us-ascii?Q?P1Avtku4+tKErzI5vKfoilHCttBjO6bewCRfV3aH3QhcV6OoAU8P2L5zfBcQ?= =?us-ascii?Q?ZX6lTbgwIArUSsMzTYv1yvpg9MdWoOKkLdaYMsgRPJyGMRI/WKq4Hu0D3MzH?= =?us-ascii?Q?b+l7LN4vrkh6dAHaXaaoXPQUIT/3i/0=3D?= Content-Language: et x-ms-exchange-organization-originalclientipaddress: 213.184.53.4 x-ms-exchange-organization-originalserveripaddress: 10.167.242.43 acceptlanguage: et-EE, en-US received-spf: None (mail1.rit.ee: no sender authenticity information available from domain of postmaster@pp-client-1.ph.ee) identity=helo; client-ip=194.126.127.60; receiver=mail1.rit.ee; envelope-from="anneli.parn@ph.ee"; x-sender="postmaster@pp-client-1.ph.ee"; x-conformance=spf_only dkim-signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=ph.ee; h= content-type:date:from:message-id:mime-version:subject:to; s= smtp; bh=QNNTFcVywNRLmAJw2aJsR1/h9ucj7ZM4IEnjpMSu1OM=; b=zBC4d2q y14G6dAyW2vFYnY6EzX/8TLUsGaszo75MykUPdqdfuNEfXDlTLMjJfGCQoe68FnO kDZrM++4cK2Yu8/PoDbaBDvDBdIs8UoAy1bDlKo2lo3pZbUEacpE7y28YBHtyXAu myF/m0NdqqYcDX6ytz66n2dTStr+MPxiai7KmICLfUL0DOZPFwKCvY1NNIyGDrkA ZqkDUSfk7HKFkPc4wqTpZSCp9Nm+lIT/5hgSDVncY9mhKje5NJRkmA6XUvZOb3iQ 5WmkY3HJBe7y/Go+fxom8MiuuvHV0SS2zNQqh7HFJ44KYvlXW9UbtUGSyHrdomaD bnIj7mkWooEK8cQ== X-OlkEid: 00000000D07AAE8E23CDBE4CA04D01CCD82FCB7E070034AD76187591974DBF6C4F76951C873A01000200000000005797C783AAECB34FA6C879FF487E64D90000000010160000821289C2165D1A4390C0540630DF8160 x-originating-ip: [10.10.8.5] x-tm-as-product-ver: SMEX-14.0.0.3239-9.1.2019-30104.006 x-tm-as-result: No-10--14.825400-8.000000 x-tmase-matchedrid: G/d+gqvw/DDkUB2YvI/ISwLidf65bNOXnHp0x5N6+xp1koH+sxwE+oJg 639c6bzEc3tla7jyNRZRAISAOsYkGeS62XWjuGwGHY/XeJlZKEUtzM8wdlz5DiTG1CpdES1k3Zv ca1xCHnhq/fAzOjhDkB077tWnwAUlvuV2/Q3kPV0Wd/c/Vdyl4FYSmaIHbAjb4gefAI4RchAvGs SQdA20SApvh5lP2+jpeupR0OokItWDXnUNoIzPJxTRT6kU85pkjQmHD3Vo9Y7HqbCM/s4xHVuJP zyHr9AwatBAv1bBtpbOkCoNyThZ4lV0twgLfg8YGqxL/yNoD8rVzTgENjEotnWyZqn3hOOM+A6y NVMBJDhjc99KY0Ed8lYHXldrySG2lQ8V38myA7/PxCDduHH07Mq27sNiu4VX2isH4xwTQCQPLkt sz+KbBQ== x-tm-as-user-approved-sender: No x-tm-as-user-blocked-sender: No x-tmase-result: 10--14.825400-8.000000 x-tmase-version: SMEX-14.0.0.3239-9.1.2019-30104.006 x-tm-snts-smtp: 2040284CB41298B0BADE6C2ABEF3F57F4B0016D5D8F25242FB829FB31DD4B98D2000:8 X-Proofpoint-GUID: 51oLo55JAeH5fIQPt3G3rAP2VfMaaQIe X-Proofpoint-ORIG-GUID: 51oLo55JAeH5fIQPt3G3rAP2VfMaaQIe X-Authority-Analysis: v=2.4 cv=ZbIt8MVA c=1 sm=1 tr=0 ts=6a6c8ad9 cx=c_pps a=le84jSDIpmDhjp19lpGFxA==:117 a=rD6rDnVn5T4A:10 a=RAioF0-LDSMA:10 a=5KLPUuaC_9wA:10 a=M51BFTxLslgA:10 a=VkNPw1HP01LnGYTKEx00:22 a=Iwic4pHs_bkqg1F8IN4f:22 a=NChB7CJbEIVCwtJyUgVS:22 a=j2ziBteEBSa_y3RmMesA:9 a=QEXdDO2ut3YA:10 a=yMhMjlubAAAA:8 a=SSmOFEACAAAA:8 a=u7zX986QgcHAOVXq:21 a=gKO2Hq4RSVkA:10 a=UiCQ7L4-1S4A:10 a=hTZeC7Yk6K0A:10 a=frz4AuCg-hUA:10 X-Proofpoint-Spam-Info: AW1haW4tMjYwNzMxMDA5MCBTYWx0ZWRfX3uuwasxEqOxe pyMgpzHZUUeKd47L252AAeTwd/CY9B9IduFhhlzYAtU9IeKEPmdH3JgsEbAIgaucSWDDEI5okwM Qh6oG5SKPfMR14vFnwgPOC4+e5G8w6ZMQyETyLBhMgxprWA7Bd/c X-Proofpoint-Spam-Details-Enc: AW1haW4tMjYwNzMxMDA5MCBTYWx0ZWRfX+XgD7F5Sdctk gAj/LG97oePzwFNJjtTiD9wt+7x51Lqf1rNCFkCbIqmibRyMIkfGKcGlOv3uhKeV8Lbqwu28kKq CsYm+paJ+WFElXGahqkURx/nrPRIiaka/N9SjeRFFzxVNpn8QY1ZIxSbOqsl9TKEqIXs8s10ga+ x8cpY2InR8SDji/6kf8S/pkHwVhGKHSme8fqd45FA0GExUgMbx9AhXCWWJfaNaRuKbe6ONAJPYe 67W0JuW6IO3UGqe+VaHILjVjw68i38zkfRCca/1xWgLj1Rqjm/GdlAjxfj5ziAWYhzy9OWe4jtd RCd2EGblHsAxxuMy/9Z740W/3o/v3lKo0RO2dZYjyU7EvRgIKUgKkrEmV9ndJBthNQd+4vIe7QV 3bjtjQSqFGOBRuYUlmjc0jvT2+Jx1cV2k70KHJICP2vj9DG7AIBeGF1Y4cgPMUvPE+etpB+0KAe +f18gUQ/OeiB9W3O9Zg== This is a multipart message in MIME format. ------=_NextPart_000_004F_01DD2102.98419930 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Lugupeetud Sotsiaalministeerium Palun Teie selgitust tervishoiuteenuste korraldamise seaduse § 3³ ja § 3⁴ kohaldamise kohta seoses ohjeldusmeetmete rakendamisega tervishoiuteenuse osutamisel. Soovin eelkõige täpsustada, milliseid vahendeid tuleb käsitada seaduse tähenduses ohjeldusvahenditena ning milliseid vahendeid ei käsitata ohjeldusvahenditena. Palun vastata järgmistele küsimustele: 1. Millised konkreetsed vahendid kuuluvad tervishoiuteenuste korraldamise seaduse § 3³ lõike 2 punkti 3 tähenduses mehaaniliste ohjeldusvahendite hulka? 2. Milliste tunnuste või kriteeriumide alusel hinnatakse, kas konkreetne vahend on käsitatav mehaanilise ohjeldusvahendina? Kas määravaks on vahendi eesmärk, konstruktsioon, kasutusviis või muu asjaolu? 3. Kas kõik meditsiiniliseks otstarbeks toodetud patsiendi liikumist piiravad rihmad, kinnitused või muud vahendid on käsitatavad mehaaniliste ohjeldusvahenditena või võivad mõned sellised vahendid jääda seaduse mõistes ohjeldusvahendite kohaldamisalast välja? 4. Palun tuua näiteid vahenditest, mida käsitatakse mehaaniliste ohjeldusvahenditena, ning näiteid vahenditest, mida ei käsitata mehaaniliste ohjeldusvahenditena. 5. Kas tervishoiuteenuse osutaja võib iseseisvalt hinnata kasutatava vahendi liigitumist ohjeldusvahendiks või on olemas riiklikud juhised, loetelud või muud kriteeriumid, millest tuleb lähtuda? 6. Kas Sotsiaalministeerium on koostanud või kavandab koostada juhendmaterjale või täpsustavaid selgitusi ohjeldusvahendite liigitamise, kasutamise tingimuste ja dokumenteerimise kohta? 7. Kuidas tõlgendab ministeerium nõuet, mille kohaselt peab ohjeldusmeede olema otsese ohuga proportsionaalne ning riivama patsiendi õigusi ja vabadusi võimalikult vähesel määral? Palun vastata käesolevas pöördumises esitatud küsimustele kirjalikult. Lugupidamisega, Anneli Pärn Patsiendiohutuse koordinaator Kvaliteediteenistus SA Pärnu Haigla Telefon +372 5309 6469 This e-mail and any attachment may contain confidential and privileged information. If you are not the intended recipient,please notify the sender immediately by return e-mail, delete this e-mail and destroy any copies. Any dissemination or use of this information by a person other than the intended recipients is unauthorized and may be illegal. ------=_NextPart_000_004F_01DD2102.98419930 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable

T=C3=A4helepanu! Tegemist on v=C3=A4lisv=C3=B5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte = avada.

Lugupeetud Sotsiaalministeerium

 

Palun Teie selgitust tervishoiuteenuste korraldamise = seaduse =C2=A7 3=C2=B3 ja =C2=A7 3=E2=81=B4 kohaldamise kohta seoses = ohjeldusmeetmete rakendamisega tervishoiuteenuse = osutamisel.

Soovin eelk=C3=B5ige t=C3=A4psustada, milliseid = vahendeid tuleb k=C3=A4sitada seaduse t=C3=A4henduses = ohjeldusvahenditena ning milliseid vahendeid ei k=C3=A4sitata = ohjeldusvahenditena.

Palun vastata j=C3=A4rgmistele = k=C3=BCsimustele:

  1. Millised = konkreetsed vahendid kuuluvad tervishoiuteenuste korraldamise seaduse = =C2=A7 3=C2=B3 l=C3=B5ike 2 punkti 3 t=C3=A4henduses mehaaniliste = ohjeldusvahendite hulka?
  2. Milliste tunnuste v=C3=B5i kriteeriumide alusel = hinnatakse, kas konkreetne vahend on k=C3=A4sitatav mehaanilise = ohjeldusvahendina? Kas m=C3=A4=C3=A4ravaks on vahendi eesm=C3=A4rk, konstruktsioon, kasutusviis v=C3=B5i muu = asjaolu?
  3. Kas k=C3=B5ik meditsiiniliseks otstarbeks = toodetud patsiendi liikumist piiravad rihmad, kinnitused v=C3=B5i muud = vahendid on k=C3=A4sitatavad mehaaniliste ohjeldusvahenditena v=C3=B5i v=C3=B5ivad m=C3=B5ned sellised vahendid j=C3=A4=C3=A4da = seaduse m=C3=B5istes ohjeldusvahendite kohaldamisalast = v=C3=A4lja?
  4. Palun tuua n=C3=A4iteid vahenditest, mida = k=C3=A4sitatakse mehaaniliste ohjeldusvahenditena, ning n=C3=A4iteid = vahenditest, mida ei k=C3=A4sitata mehaaniliste = ohjeldusvahenditena.
  5. Kas tervishoiuteenuse osutaja v=C3=B5ib = iseseisvalt hinnata kasutatava vahendi liigitumist ohjeldusvahendiks = v=C3=B5i on olemas riiklikud juhised, loetelud v=C3=B5i muud kriteeriumid, millest tuleb l=C3=A4htuda?
  6. Kas = Sotsiaalministeerium on koostanud v=C3=B5i kavandab koostada = juhendmaterjale v=C3=B5i t=C3=A4psustavaid selgitusi ohjeldusvahendite = liigitamise, kasutamise tingimuste ja dokumenteerimise kohta?
  7. Kuidas = t=C3=B5lgendab ministeerium n=C3=B5uet, mille kohaselt peab = ohjeldusmeede olema otsese ohuga proportsionaalne ning riivama patsiendi = =C3=B5igusi ja vabadusi v=C3=B5imalikult v=C3=A4hesel m=C3=A4=C3=A4ral?

Palun vastata k=C3=A4esolevas p=C3=B6=C3=B6rdumises = esitatud k=C3=BCsimustele kirjalikult.

 

Lugupidamisega,

Anneli P=C3=A4rn

 

Patsiendiohutuse koordinaator

Kvaliteediteenistus

SA P=C3=A4rnu Haigla

Telefon +372 5309 6469

 


This e-mail and any attachment may contain confidential and privileged = information. If you are not the intended recipient,please notify the = sender immediately by return e-mail, delete this e-mail and destroy any = copies. Any dissemination or use of this information by a person other than the intended recipients is unauthorized and may = be illegal.

------=_NextPart_000_004F_01DD2102.98419930--